Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Nxera Pharma Webinar for Financial Results Presentation - 2Q2026
Tokyo, Japan and Cambridge and London, UK, 15 July 2026 – Nxera Pharma Co. Ltd (“Nxera”; TSE 4565) will announce its earnings results and present operational highlights for 2Q 2026 on Friday, 7 August 2026. The Company will…
Sun Pharma gets nod from South African regulator for generic semaglutide injection
Sun Pharmaceutical Industries Ltd. on Wednesday (July 15, 2026) said it has received approval from the South African regulator to manufacture and market a generic version of semaglutide injection in the country for treatment of adults with type 2…
IPC signs MoU with UP Promote Pharma Council to strengthen quality standards
The Indian Pharmacopoeia Commission (IPC) has signed a memorandum of understanding (MoU) with the Uttar Pradesh Promote Pharma Council (UPPPC) to strengthen quality standards, regulatory compliance and innovation across the pharmaceutical and…
Sun Pharma gets go-ahead in South Africa to sell generic semaglutide
Drugmaker Sun Pharmaceutical Industries has received the green signal from the South African Health Products Regulatory Authority (SAHPRA) to manufacture and market a generic version of semaglutide injection in South Africa for the treatment of…
Calamos Advisors LLC Takes Position in Royalty Pharma PLC $RPRX
Calamos Advisors LLC acquired a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The fund acquired 437,090 shares of the biopharmaceutical company's stock, valued at…
Urogen Pharma (NASDAQ:URGN) Reaches New 52-Week High - What's Next?
Urogen Pharma (NASDAQ:URGN - Get Free Report) shares hit a new 52-week high during mid-day trading on Wednesday. The stock traded as high as $40.40 and last traded at $39.19, with a volume of 556070 shares traded. The stock had previously closed at…
Boehringer Ingelheim reports first-half 2026 sales growth, driven by JARDIANCE and new product launches in the U.S.
Strong U.S. demand and new product launches drive first-half sales in Human Pharma Net sales reach EUR 15.8 billion, led by JARDIANCE and successful U.S. launches Positive Phase III data for survodutide and pipeline progress strengthen long-term…
Royalty Pharma PLC $RPRX Shares Sold by J. Safra Sarasin Holding AG
J. Safra Sarasin Holding AG cut its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 76.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned…
Principal Financial Group Inc. Has $205.03 Million Holdings in Ascendis Pharma A/S $ASND
Principal Financial Group Inc. trimmed its position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 12.7% in the first quarter, according to its most recent filing with the SEC. The fund owned 896,397 shares of the biotechnology company's…
Why Semaglutide is an inflection point for India's generics sector?
More than a supply chain issue and missing the first mover status, Semaglutide episode has rather exposed systemic chinks and could prove costly for India's pharmaceutical industry, which supplies about 20% of the world's generic medicines by…
45,611 Orion Corporation A shares converted into B shares
STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 45,611 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 45,611 A…
The Best Careers Are Built On Taking Risk, Not Hedging Your Bets
Bill Holodnak, CEO and Founder of Occam Global, an executive search and advisory firm focused on leadership across the innovation economy. There's a persistent belief that career success follows a rational path: work hard, make smart decisions and…
ARS Pharmaceuticals (SPRY) Appoints Donn Casale As The New CEO
ARS Pharmaceuticals Inc. (NASDAQ: SPRY) is one of the 10 best stocks under $10 that could triple. On July 8, ARS Pharmaceuticals Inc. (NASDAQ:SPRY) disclosed a CEO transition, and effective July 6, the company's Co-founder and Chief Executive…
/afaqs/media/media_files/2026/07/15/revital-2026-07-15-15-45-40.jpg)
Revital highlights the impact of stress in new ad with Vicky Kaushal
Revital, the multivitamin brand from Sun Pharmaceutical Industries, has launched an integrated campaign featuring actor Vicky Kaushal. The campaign focuses on how stress and the demands of modern lifestyles may contribute to everyday fatigue beyond…
Does International Flavors and Fragrances (IFF) Discounted Valuation Unlocks Opportunity?
Heartland Advisors, an investment management company, released its second-quarter 2026 investor letter for 'Heartland Mid Cap Value Fund'. A copy can be downloaded here. Mid-cap stocks sharply rose in the second quarter, driven by perceived AI…
Receive a Daily briefing on Pharma Industry News
Get Started